Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1976 1
1977 1
1978 1
1979 1
1980 1
1981 7
1982 3
1983 12
1984 8
1985 8
1986 9
1987 14
1988 15
1989 19
1990 18
1991 19
1992 20
1993 26
1994 19
1995 29
1996 30
1997 27
1998 40
1999 39
2000 38
2001 40
2002 39
2003 32
2004 48
2005 43
2006 78
2007 58
2008 83
2009 71
2010 58
2011 64
2012 60
2013 58
2014 59
2015 66
2016 45
2017 32
2018 50
2019 66
2020 61
2021 82
2022 56
2023 58
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,566 results

Results by year

Filters applied: . Clear all
Page 1
Dual Targeting CAR-T Cells with Optimal Costimulation and Metabolic Fitness enhance Antitumor Activity and Prevent Escape in Solid Tumors.
Hirabayashi K, Du H, Xu Y, Shou P, Zhou X, Fucá G, Landoni E, Sun C, Chen Y, Savoldo B, Dotti G. Hirabayashi K, et al. Nat Cancer. 2021 Sep;2(9):904-918. doi: 10.1038/s43018-021-00244-2. Epub 2021 Sep 23. Nat Cancer. 2021. PMID: 34746799 Free PMC article.
Molecular and signaling studies indicate that T cells engineered with the proposed CAR design demonstrate sustained phosphorylation of T cell receptor-associated (TCR) signaling molecules and a molecular signature supporting CAR-T cell proliferation and long- …
Molecular and signaling studies indicate that T cells engineered with the proposed CAR design demonstrate sustained phosphorylation o …
Enzyme assay of β1,3-glycosyltransferase family.
Togayachi A. Togayachi A. 2021 Dec 20 [updated 2022 Mar 28]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. 2021 Dec 20 [updated 2022 Mar 28]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. PMID: 37590747 Free Books & Documents. Review. No abstract available.
Embracing complexity in Drosophila cancer models.
Choutka C, Cabrera C, Hirabayashi S. Choutka C, et al. Dis Model Mech. 2022 Mar 1;15(3):dmm049513. doi: 10.1242/dmm.049513. Epub 2022 Mar 28. Dis Model Mech. 2022. PMID: 35344038 Free PMC article.
Enrichment strategies for glycopeptides.
Ito S, Hayama K, Hirabayashi J. Ito S, et al. Methods Mol Biol. 2009;534:195-203. doi: 10.1007/978-1-59745-022-5_14. Methods Mol Biol. 2009. PMID: 19277551 Review.
Oral Pharmacotherapy for Benign Essential Blepharospasm.
Hirabayashi KE, Vagefi MR. Hirabayashi KE, et al. Int Ophthalmol Clin. 2018 Winter;58(1):33-47. doi: 10.1097/IIO.0000000000000208. Int Ophthalmol Clin. 2018. PMID: 29239876 Review. No abstract available.
CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo.
Alajati A, D'Ambrosio M, Troiani M, Mosole S, Pellegrini L, Chen J, Revandkar A, Bolis M, Theurillat JP, Guccini I, Losa M, Calcinotto A, De Bernardis G, Pasquini E, D'Antuono R, Sharp A, Figueiredo I, Nava Rodrigues D, Welti J, Gil V, Yuan W, Vlajnic T, Bubendorf L, Chiorino G, Gnetti L, Torrano V, Carracedo A, Camplese L, Hirabayashi S, Canato E, Pasut G, Montopoli M, Rüschoff JH, Wild P, Moch H, De Bono J, Alimonti A. Alajati A, et al. J Clin Invest. 2020 May 1;130(5):2435-2450. doi: 10.1172/JCI131133. J Clin Invest. 2020. PMID: 32250342 Free PMC article.
Assay method for the antiproliferative activity of human galectin-9.
Itoh A, Nishi N. Itoh A, et al. 2021 Jul 29 [updated 2022 Mar 16]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. 2021 Jul 29 [updated 2022 Mar 16]. In: Nishihara S, Angata K, Aoki-Kinoshita KF, Hirabayashi J, editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021–. PMID: 37590616 Free Books & Documents. Review. No abstract available.
1,566 results